We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBQ
10826
DELISTED
BBQ Holdings, Inc. Common Stock
BBQ
$160K ﹤0.01%
+15,362
New +$201K
AHRT
10827
AH Realty Trust
AHRT
$506M
$159K ﹤0.01%
12,442
-33,504
-73% -$455K
AMTX icon
10828
Aemetis
AMTX
$128M
$159K ﹤0.01%
32,292
+22,136
+218% +$193K
NKTR icon
10829
PUT
Nektar Therapeutics
NKTR
$2.49B
$159K ﹤0.01%
2,793
-56,267
-95% -$3.55M
MKFG
10830
CALL
DELISTED
Markforged Holding Corporation
MKFG
$159K ﹤0.01%
8,590
+2,950
+52% +$86.2K
GAQ.U
10831
DELISTED
Generation Asia I Acquisition Limited Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
GAQ.U
$159K ﹤0.01%
16,089
-403
-2% -$3.98K
APPH
10832
PUT
DELISTED
AppHarvest, Inc. Common Stock
APPH
$159K ﹤0.01%
45,500
-31,800
-41% -$114K
CTAQU
10833
DELISTED
Carney Technology Acquisition Corp. II Units
CTAQU
$159K ﹤0.01%
15,972
-201
-1% -$1.99K
RJA
10834
DELISTED
AB Svensk Ekportkredit ELEMENTS Linked to the Rogers International Commodity Index-Agriculture Total Return
RJA
$159K ﹤0.01%
+16,978
New +$177K
RNWK
10835
CALL
DELISTED
RealNetworks Inc
RNWK
$159K ﹤0.01%
251,400
+31,400
+14% +$18.2K
ADCT icon
10836
CALL
ADC Therapeutics
ADCT
$129M
$158K ﹤0.01%
19,900
+700
+4% +$6.62K
PFLT icon
10837
PUT
PennantPark Floating Rate Capital
PFLT
$730M
$158K ﹤0.01%
13,800
+2,700
+24% +$33.5K
TRDA icon
10838
Entrada Therapeutics
TRDA
$290M
$158K ﹤0.01%
12,947
-51,452
-80% -$390K
AUST icon
10839
Austin Gold Corp
AUST
$17.9M
$157K ﹤0.01%
+86,696
New +$179K
CIA icon
10840
Citizens
CIA
$201M
$157K ﹤0.01%
+37,470
New +$135K
DYAI icon
10841
Dyadic International
DYAI
$28.2M
$157K ﹤0.01%
51,405
+36,842
+253% +$91.1K
HOOK
10842
DELISTED
HOOKIPA Pharma
HOOK
$157K ﹤0.01%
9,681
+5,528
+133% +$91.5K
RLJ icon
10843
CALL
RLJ Lodging Trust
RLJ
$1.67B
$157K ﹤0.01%
+14,200
New +$185K
VWE
10844
CALL
DELISTED
Vintage Wine Estates, Inc. Common Stock
VWE
$157K ﹤0.01%
20,000
-29,000
-59% -$267K
ACH
10845
CALL
DELISTED
Alum Corp of China Ltd
ACH
$157K ﹤0.01%
+16,500
New +$188K
APYX icon
10846
PUT
Apyx Medical
APYX
$128M
$156K ﹤0.01%
+26,600
New +$136K
CTXR icon
10847
CALL
Citius Pharmaceuticals
CTXR
$20.7M
$156K ﹤0.01%
6,776
+1,668
+33% +$45.7K
CURV icon
10848
Torrid Holdings
CURV
$219M
$156K ﹤0.01%
36,221
-42,347
-54% -$238K
LIND icon
10849
CALL
Lindblad Expeditions
LIND
$2.2B
$156K ﹤0.01%
19,300
+1,600
+9% +$20.9K
NAK
10850
CALL
Northern Dynasty Minerals
NAK
$908M
$156K ﹤0.01%
597,100
-129,400
-18% -$42.3K

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.